A detailed history of Atwood & Palmer Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Atwood & Palmer Inc holds 19 shares of BSX stock, worth $1,987. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19
Previous 203 90.64%
Holding current value
$1,987
Previous $18,000 94.44%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 15, 2025

SELL
$89.38 - $106.18 $16,445 - $19,537
-184 Reduced 90.64%
19 $1,000
Q4 2024

Jan 16, 2025

SELL
$83.62 - $91.5 $501 - $549
-6 Reduced 2.87%
203 $18,000
Q3 2024

Oct 07, 2024

BUY
$72.96 - $84.0 $13,862 - $15,960
190 Added 1000.0%
209 $17,000
Q2 2024

Jul 10, 2024

SELL
$67.33 - $77.71 $4,376 - $5,051
-65 Reduced 77.38%
19 $1,000
Q1 2024

Apr 10, 2024

BUY
$57.6 - $68.62 $3,744 - $4,460
65 Added 342.11%
84 $5,000
Q4 2023

Jan 12, 2024

BUY
$48.64 - $57.81 $924 - $1,098
19 New
19 $1,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $150B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Atwood & Palmer Inc Portfolio

Follow Atwood & Palmer Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atwood & Palmer Inc, based on Form 13F filings with the SEC.

News

Stay updated on Atwood & Palmer Inc with notifications on news.